VABYSMO: REAL WORLD EVIDENCE

Make Vabysmo your first choice
This real-world clinical case presents the course of a patient with untreated diabetic macular edema (DME), highlighting the visual and anatomical response observed during treatment with VABYSMO®. The case demonstrates rapid and sustained visual gains, along with a reduction in central retinal thickness, allowing for the progressive extension of treatment intervals up to 12 weeks.

DME patient whose poor vision was affecting quality time with her grandchildren

DME patient whose poor vision was affecting quality time with her grandchildren

VABYSMO maintained vision gains and drying through 1 year

VABYSMO delivered rapid and sustained vision gains and drying, allowing extension to Q12W
Access the material for more information

Downloadable content

Material created by Roche. | All rights reserved - reproduction in whole or in part is prohibited without the prior written authorization of Roche Servicios S.A.

This material may contain information regarding investigational medicinal products or active substances, or indications not yet approved in your country, with the aim of providing medical and/or scientific information of interest to healthcare professionals. Roche does not recommend the use of any product in any indication, dosage, or route of administration that is not clearly listed in the product insert or marketing authorization approved by the local regulatory authority. | For healthcare professionals only.

This product is approved in all countries in the Caribbean, Central America and Venezuela region.
By clicking "Continue" you will access content that may not be owned by Roche. If so, Roche assumes no responsibility for the access, use and content of this website. If you want to stay on Dialogo Roche, click on "Close".
Restricted

Bookmarking is available only for logged-in users.

Sign up Log in